Monitoring Genetic and Metabolic Potential for In-Site Bioremediation: Mass Spectrometry by Buchanan, M.V.
FINAL REPORT
U.S. Department of Energy
Monitoring Genetic and Metabolic Potential for in situ  Bioremediation:
Mass Spectrometry
Principal Investigator: Michelle V. Buchanan
Institution: Oak Ridge National Laboratory
Collaborators:
At Oak Ridge National Laboratory:
Gregory B. Hurst
David P. Allison
Phillip F. Britt
Mitchel J. Doktycz
Yongseong Kim
Kristal Weaver
At The  University of Washington:
Mary E. Lidstrom
Andria M. Costello
Ann Auman
Project Number:  55108
Grant Project Officers:
SC Point of Contact:  Dr. Roland Hirsch
EM Point of Contact:  Chester E. Miller
Project Duration: 10/1/96-3/31/00
2Table of Contents
Executive Summary 3
Research Objectives 6
Methods and Results 7
Relevance, Impact and Technology Transfer 17
Project Productivity 19
Personnel Supported 19
Publications 20
Interactions 21
Transitions 21
Future Work 22
Appendix 25
3Executive Summary
A number of DOE sites are contaminated with mixtures of dense non-aqueous phase liquids
(DNAPLs) such as carbon tetrachloride, chloroform, perchloroethylene, and trichloroethylene.
At many of these sites, in situ microbial bioremediation is an attractive strategy for cleanup,
since it has the potential to degrade DNAPLs in situ without producing toxic byproducts or
expensive removal procedures.  A rapid screening method to determine broad range potential
for contaminant degradation by microbes would greatly reduce the cost and time involved in
assessment for in situ bioremediation, as well as for monitoring ongoing bioremediation
treatment.
The objective of this project was the development of mass-spectrometry-based methods to
screen for genetic potential for both assessment and monitoring of in situ bioremediation of
DNAPLs.  These methods were designed to provide more robust and routine methods for DNA-
based characterization of the genetic potential of subsurface microbes for degrading pollutants.
Specifically, we sought to 1.  Develop gene probes that yield information equivalent to
conventional probes, but are more amenable to mass spectrometric detection,  2.  Pursue
improvements to mass spectrometry methodology in order to allow more general application to
gene probe detection,  3.  Increase the throughput of microbial characterization by integrating
gene probe preparation, purification, and MALDI-MS analysis.
In this EMSP project (for which funding ended in March 2000), we demonstrated proof of
principle for the idea of using mass spectrometry as a readout technique for gene probe assays
of microbes relevant to bioremediation.  The project was a collaborative effort between Oak
Ridge National Laboratory (ORNL) and Professor Mary Lidstrom’s group at the University of
Washington.
4Prof. Lidstrom’s group developed molecular techniques for analyzing natural populations of
methanotrophic bacteria.  A DNA sequence database was developed for methanotrophs in Lake
Washington sediment, and used to design assays specific for selected diagnostic genes in
methanotrophs.  These molecular tools were used to analyze the natural populations of
methanotrophs in Lake Washington sediments by conventional hybridization techniques.  A
major surprise from this work was the finding that a significant segment of the natural population
are sMMO-containing Methylomonas strains, which are of interest because they have the
potential to carry out high rate degradation of trichloroethylene.  New primers have been
designed to detect this group of organisms.
At ORNL, we have used these tailored products as a model system in developing a streamlined
MALDI-MS protocol.  We have characterized these products and examined the effects of
interferences on our protocol.  Aspects of this protocol include a rapid method for preparing
PCR products for MALDI-MS analysis, parallel implementation of this purification, and
automated MALDI-MS data acquisition.  We have achieved advances in figures of merit for
MALDI-MS analysis of PCR products, including mass range, resolution, and reproducibility.
Relevance, Impact, and Technology Transfer:  The issues addressed by this project involve
technology to increase the applicability of in-situ bioremediation for DNAPL, or potentially any
microbially-degraded pollutant.  We have applied fundamental knowledge in molecular biology
and analytical chemistry to the problem of rapidly characterizing microbial populations at
potential cleanup sites.  The project was a collaboration between the Organic and Biological
Mass Spectrometry group at Oak Ridge National Laboratory (ORNL), and Professor Mary
Lidstrom’s research group at the University of Washington.  Two Ph.D. students in Prof.
Lidstrom’s laboratory worked on this project;  Andria Costello’s thesis, “Molecular Ecology
5Studies of Methanotrophs in a Freshwater Lake Sediment,” (available as UMI # 9930380 from
UMI, 300 N. Zeeb Rd, Ann Arbor, MI) describes their results, and Ann Auman is currently
completing her thesis research.  Two postgraduate research associates, Dr. Yongseong Kim
and Ms. Kristal Weaver, participated in the research at ORNL.  While the work resulted in proof
of principle for mass spectrometry-based detection of microbial gene probes, further work needs
to be done to develop a wider array of suitable probes, and to refine the mass spectrometry
methodology before the knowledge gained in the project will be directly applicable to DOE
Environmental Management problems.
6Research Objectives
A number of DOE sites are contaminated with mixtures of dense non-aqueous phase liquids
(DNAPLs) such as carbon tetrachloride, chloroform, perchloroethylene, and trichloroethylene.
At many of these sites, in situ microbial bioremediation is an attractive strategy for cleanup,
since it has the potential to degrade DNAPLs in situ without the need for pump-and-treat or soil
removal procedures, and without producing toxic byproducts.  A rapid screening method to
determine broad range metabolic and genetic potential for contaminant degradation would
greatly reduce the cost and time involved in assessment for in situ bioremediation, as well as for
monitoring ongoing bioremediation treatment.
The objective of this project was the development of mass-spectrometry-based methods to
screen for genetic potential for both assessment and monitoring of in situ bioremediation of
DNAPLs.  These methods were designed to provide more robust and routine methods for DNA-
based characterization of the genetic potential of subsurface microbes for degrading pollutants.
Specifically, we sought to 1.  Develop gene probes that yield information equivalent to
conventional probes, but in a smaller size that is more amenable to mass spectrometric
detection,  2.  Pursue improvements to matrix-assisted laser desorption/ionization mass
spectrometry (MALDI-MS) methodology in order to allow its more general application to gene
probe detection,  3.  Increase the throughput of microbial characterization by integrating gene
probe preparation, purification, and MALDI-MS analysis.
Effective decision-making regarding remediation strategies requires information on the
contaminants present and the relevant hydrogeology.  However, it also should include informa-
tion on the relevant bacterial populations present and the biodegradative processes they carry
out.  For each site at which bioremediation is considered, it is necessary to determine whether
sufficient intrinsic degradative capability is present to suggest intrinsic bioremediation as a via-
ble option, or whether a strategy involving addition of specific nutrients is more likely to be suc-
cessful.  In addition, if the existing genetic potential does not include the desired processes, it
may be necessary to add external organisms as well as nutrients, which would negatively
impact cost and feasibility scenarios.  Once a bioremediation strategy is decided upon and
initiated, it is important to carry out monitoring of the bacteria and their activities.  Real-time data
of this type during the treatment process can allow ongoing evaluation to optimize biodegra-
dation, reducing cost and avoiding possible toxic byproducts.  Clearly, the development of novel
bioremediation technologies and informed decision-making regarding bioremediation as a treat-
ment option will require in-depth information on the bacteria present at each site and the pro-
cesses they carry out.  Currently such information is generated by labor- and time-intensive
treatability tests in the laboratory, and these do not generally assess a broad range of metabolic
processes.  We undertook this project because a rapid screening method to evaluate genetic
potential is an important development to reduce costs for implementing in situ bioremediation
strategies at DOE sites.
At the outset of this project, it was clear that the explosion of information in the DNA sequence
database raised the possibility of developing diagnostic DNA signatures for key microbial
processes, as a means for assessing genetic potential.  The methods developed in our project
would be able to take advantage of the growing information on sequences from environmental
samples as well as from microbial genome sequencing projects.  An increasing number of
metabolic functions could be screened as the depth of information available for designing
diagnostic sequences increased.
7To apply the growing microbial sequence data to characterization of microbial populations, it is
necessary to be able to detect specific DNA signature sequences.  The application of gene
probes to characterization of metabolic potential of microbial populations at the DOE Savannah
River Site has been carried out using methods similar to these [Bowman et al., 1993].  Current
methods involve amplifying DNA using the polymerase chain reaction (PCR) or other
amplification procedures to make multiple copies of a characteristic DNA fragment [Gibbs,
1990].  Detection of PCR products has conventionally been performed by gel electrophoresis or
by hybridization with a complementary, labeled DNA probe.  These techniques can be slow or
yield ambiguous results, do not lend themselves to rapid, routine screening of many samples,
and are generally viewed as the major bottleneck in many molecular biology laboratories.
To eliminate this bottleneck, we set out to perform research that would allow the use of mass
spectrometry as a replacement “readout” technology for gene probe assays.  Mass
spectrometry is a method for measuring mass-to-charge ratios (m/z) of gas-phase ions.  In the
1980’s, advances in ionization processes, such as matrix-assisted laser desorption/ionization
(MALDI) [Hillenkamp et al., 1991] and electrospray (ES) ionization [Fenn et al., 1989] allowed
analysis of large biomolecules, including DNA oligomers, by mass spectrometry.  When used for
detection of PCR products, mass spectrometry yields information similar to electrophoresis, with
DNA size information read directly from the peaks in the mass spectrum, but with analysis times
reduced by several orders of magnitude compared to electrophoresis [Doktycz et al., 1995; Bai
et al., 1995; Wunschel et al., 1996].   The Organic and Biological Mass Spectrometry Group at
ORNL has developed a mass spectrometry-based method for identifying small DNA signature
molecules produced by PCR amplification from natural samples. [Doktycz et al., 1995]  The
efficacy of this concept was demonstrated by successful amplification and MALDI-MS detection
of PCR products from Legionella pneumophila [Hurst et al., 1996] and, under this EMSP project,
methanotrophic bacteria.[Hurst et al., 1998a, b]  Mass spectrometric detection is improved by
concentrating on designing PCR products that are smaller than, but retain equivalent
information to, PCR products conventionally detected using gel electrophoresis.  This method
has the potential for detecting DNA signature molecules much more rapidly and with more
specificity than existing techniques.  It also has the potential to be automated.
This project made substantial progress along a path toward more rapid analysis of microbial
PCR products, using MALDI-MS instead of traditional gel electrophoretic or hybridization
methods.  The long-term payoff of the described research would be a much higher-throughput
analytical method with enhanced accuracy, providing a valuable tool for microbiologists in
evaluating and modifying environmental microbial populations.  Ultimately, this work could lead
to the identification of a suite of diagnostic DNA sequences that can be measured to assess
bioremediation processes.  These technologies could then be incorporated into a field-portable
mass spectrometer so that these parameters can be determined on site.  Although construction
of such a device was outside the scope of this project, such a system could be used for initial
laboratory-based site characterization and also to monitor bioremediation processes during their
implementation.
Methods and Results
In this EMSP project (for which funding ended in March 2000), we demonstrated proof of
principle for the idea of using MALDI-MS as a readout technique for gene probe assays (PCR in
particular) of microbes relevant to bioremediation.  Professor Lidstrom’s group at the University
of Washington designed special PCR products that are tailored for detection by MALDI-MS.
The importance of these PCR products is that they are small enough to allow robust detection
8by MALDI-MS, yet contain equivalent information to the larger PCR products that are typically
designed for conventional detection techniques.  At ORNL, we have used these tailored
products as a model system in developing a streamlined MALDI-MS protocol.  We have
characterized these products and examined the effects of interferences on our protocol.
Aspects of this protocol include a rapid method for preparing PCR products for MALDI-MS
analysis, parallel implementation of this purification, and automated MALDI-MS data acquisition.
We have achieved advances in figures of merit for MALDI-MS analysis of PCR products,
including useable mass range, resolution, and reproducibility.
Prof. Lidstrom’s group at the University of Washington developed molecular techniques for
analyzing natural populations of methanotrophic bacteria.  The initial study focused on Lake
Washington sediments, a habitat studied in detail by the Lidstrom laboratory.  A sequence
database was developed for methanotrophs in Lake Washington sediment, both from isolated
strains and from environmental clone banks for three sets of diagnostic genes, 16S rRNA,
pmoA (encoding a subunit of the particulate methane monooxygenase) and mmoX (encoding a
subunit of the soluble methane monooxygenase).  This database was used to design PCR
primers and hybridization probes specific for these sets of diagnostic genes that will detect the
entire range of these genes in known methanotrophs.  These molecular tools were used to
analyze the natural populations of methanotrophs in Lake Washington sediments by
conventional hybridization techniques.  Part of this work has been published (Costello and
Lidstrom 1999).  A major surprise from this work was the finding that a significant segment of
the natural population are sMMO-containing Methylomonas strains.  These strains are of
interest because they have the potential to carry out high rate degradation of trichloroethylene
(TCE) and are more easily enriched than the classical Methylosinus strains that are normally the
target of methane-enhanced bioremediation protocols.  New primers have been designed to
detect this group of organisms.
This traditional analysis was performed in concert with new analysis methods using MALDI-MS.
The first step was to use the new sequence database to design PCR primers to amplify 56- and
99-base pair regions from the pmoA gene that encodes the particulate methane
monooxygenase enzyme.  These relatively short PCR products are specific to two major groups
of methanotrophs, type I (represented by Methylomicrobium albus BG8) and type II
(represented by Methylosinus trichosporium OB3b).  The UW group shared primer sequences,
bacterial genomic DNA, and information on PCR conditions with the ORNL group, allowing the
PCR products to be generated at ORNL as needed for mass spectrometry experiments.
Using these products as a model, we developed a robust purification and MALDI-MS protocol
that allows detection of these products from a single 25 mL PCR preparation [Hurst et al., 1998a,
b;  Buchanan et al., 1998].  Figure 1 compares MALDI-MS spectra of the type II methanotroph
PCR product from the pmoA gene, before and after the reverse-phase purification.  The purified
product shows a higher signal-to-noise ratio and improved resolution (narrower peaks).
Individual components of the PCR product are resolved in the purified product;  these may
correspond to sequence heterogeneity and non-templated addition of an extra base by the
polymerase enzyme.  They do not appear to be MALDI artifacts such as fragmentation or
adduction, as illustrated by Figure 2.  This spectrum was obtained from a mixture of a synthetic
DNA 50-mer and a purified type II pmoA PCR product.  The peak due to the synthetic 50-mer
does not show significant fragmentation or adduction, yet the PCR product shows several
peaks.  It is thus most likely that the several peaks observed for the PCR product are actually
produced in the reaction, rather than being MALDI artifacts.  It should be noted that while PCR
produces double-stranded DNA, the MALDI process generally “melts” the product into the single
9strands, each of which will have its own base composition and molecular mass which, if
sufficiently different, could be resolved in the MALDI-MS spectrum.
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Figure 1.  Comparison of MALDI-MS spectra before and after rapid reverse-phase
purification of 56-mer type II methanotroph PCR product.
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Figure 2.  Negative-ion MALDI-MS mass spectrum of 5 picomoles of a synthetic 50-mer
(calculated mass 15315 Da) and a type II methanotroph pmoA PCR product.
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Having developed conditions for MALDI-MS measurement of the pure PCR products, we then
explored the effects of various potential interferences on the assays.
We demonstrated first that no products from cross amplification reactions were detected for the
two methanotroph assays developed at the University of Washington.  Figures 3 and 4 illustrate
this result for the type II and type I assays, respectively.  PCR reactions were prepared using
type II PCR primers, combined with either type II genomic DNA (which should yield an
amplification product), type I genomic DNA (which should result in no amplification), or no
added bacterial genomic DNA (should give no product; a “blank”).  Figure 3 shows that a
product at the expected m/z for the type II product (~17,400 Da) was detected only when type II
DNA was present;  no cross-amplification or contamination of the reactions was observed.
Similarly, Figure 4 shows that a type I product was observed from a PCR that contained type I
primers and type I chromosomal DNA, but no amplification occurred with type I primers
combined with type II chromosomal DNA or a blank.  As Figures 3 and 4 show, the primer pairs
developed for two closely-related bacteria do not cross-amplify.  Although this simple
demonstration does not preclude the possibility of false positives in other cases, the specificity
of PCR primer pairs combined with the ability to measure the size of the resulting PCR product
greatly diminishes the possibility that our approach would falsely indicate the presence of a
targeted gene sequence due to unintended amplification of interfering DNA.  Obviously, many
more species would be present in a real sample, and further work would be required to evaluate
the utility of the assay in such a situation.
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Figure 3.  Negative-ion MALDI-MS mass spectra obtained from PCR reactions using the type II
primer set with either type I or type II chromosomal DNA or no added DNA (“water”).
Groundwater, soil, or any other subsurface sample will harbor a rich mixture of different
microbes, and the potential for this diverse microbial population to contain species that could
interfere with a PCR designed to probe a single type of gene must be considered.  In addition to
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the issue of false positives addressed by the experiments summarized in Figures 3 and 4, DNA
from other organisms can decrease amplification efficiency of the targeted DNA by, for example,
complexing Mg2+ needed by the polymerase enzyme.  To determine whether “interfering” DNA
could negatively impact our pmoA assays, we performed PCR on mixtures of genomic DNA
from Methylosinus trichosporium OB3b and E. coli, the latter acting as the interference DNA in
the assay.  Figure 5 shows MALDI mass spectra for 10:1, 1:1, and 1:10 ratios of target to
interfering DNA used in the PCR.  The PCR product from the targeted organism is observed in
all cases, indicating that the effect of the interference DNA was negligible under these
conditions.
To investigate the detection sensitivity of our method, we varied the starting amount of bacterial
DNA carried through the entire process of PCR amplification, purification, and MALDI-MS
detection.  Figure 6 shows MALDI spectra of the 56-mer PCR product from Methylosinus
trichosporium OB3b, for different starting amounts of genomic bacterial DNA in the PCR.
MALDI signal can be detected from a PCR preparation that uses as little as 1.3 ng of bacterial
genomic DNA, corresponding to approximately 105 -106 target molecules (assuming a similar
genome size for M. trichosporium and E. coli bacteria [Innis and Gelfand, 1990].  This result
could probably be extended to smaller amounts of starting material by optimizing PCR
conditions for low numbers of targets.
As described above in the discussion of Figure 1, we interfaced PCR with MALDI-MS detection
using a simple solid-phase extraction procedure to remove reagents that are necessary for the
PCR, but that subsequently interfere with MALDI-MS size measurement of the amplified DNA.
To address the issue of applying our results to large numbers of samples that would be
encountered in evaluating or monitoring the bioremediation potential of a site, we scaled up this
PCR purification method to a 96-well microtiter plate format, and made progress in automating
MALDI-MS data acquisition for up to 100 samples [Weaver et al., 1998] using a commercial
MALDI-MS instrument (PerSeptive Biosystems Voyager DE) acquired with EMSP and DOE
OBER funding.  Figure 7 shows sixteen MALDI-MS spectra obtained from a 96-well purification
of the 56-mer pmoA PCR product from the type II methanotroph.  A number of PCR’s were
pooled for this purification experiment to reduce the variation due to amplification differences,
allowing us to concentrate on well-to-well differences in the purification and in the automated
MALDI data acquisition.  Some positions of the 96-well purification device were loaded with a
synthetic DNA 50-mer for calibration and quality assurance purposes.  The purification was
performed on all 96 samples in parallel, so that the entire purification required only
approximately 30 minutes.  This time could be reduced further with robotic pipetting.  Recovery
of the PCR product, measured using an intercalating fluorescent dye, is 60-70% over the range
of product sizes from 50 (primer dimer) up to 200 base pairs.  After purification, each sample
was mixed with MALDI matrix solution and transferred to a spot on the 100-position sample
plate.  The automated data acquisition capabilities of the mass spectrometer were used, and
MALDI-MS spectra of the samples were obtained without user intervention.  This data
acquisition required approximately 3 hours.  Note in Figure 7 that the 56-mer PCR product is
detected with quite good signal-to-noise.  Typically, ~90% of the MALDI spots from a 96-well
purification yielded robust 56-mer signal in the automated MALDI-MS data acquisition mode,
requiring the remaining 10% of the spots to be analyzed manually.  While the resolution (related
to the narrowness of the peaks) is somewhat variable, the selectivity afforded by the PCR (i.e.,
products of only a single size are likely to be produced) does not require all spectra to be
optimally resolved in order to obtain useful information on the presence or absence of bacterial
genes relevant to bioremediation.  Our rapid, parallel purification technique is thus an effective
interface between PCR and MALDI-MS.  A manuscript describing the 96-well purification and
automated MALDI data acquisition is in preparation.
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Figure 4.  Negative-ion MALDI-MS mass spectra obtained from (upper two spectra) single-
stranded synthetic 99-mers and (lower three spectra) PCR reactions using type I primers with
either type I or type II chromosomal DNA or no added DNA.
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Figure 5.  MALDI detection of methanotroph PCR product amplified in the presence of E. coli
DNA.
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Figure 6.  MALDI detection of 56-mer product from PCR amplifications performed using different
starting amounts (shown in the figure) of bacterial genomic DNA.  Resolution was not optimized
in this case.
Because of the large number of existing PCR assays that were designed for conventional
detection techniques and amplify target regions in the 100-500 base pair size range, MALDI-MS
would be more generally useful if it were applicable to PCR products larger than the specially-
designed 56-mer and 99-mer described above.  Figure 8 shows MALDI spectra of a 50-mer, a
100-mer, and a 200-mer PCR product, illustrating that while we can indeed detect fairly large
products, there remains a need for further work.  Note that the peaks increase in breadth with
increasing molecular mass.  This means that is more difficult to resolve closely-spaced products
at the larger size range.  The signal to noise ratio (S/N) also decreases with increasing PCR
product size.  Thus, although it is possible to detect at least up to a 200-mer in a semi-routine
fashion, and 500-600 mers have been reported [Tang et al., 1994; Liu et al., 1995], it is still
easier to analyze sizes below this limit at present, such as those developed by Dr. Lidstrom’s
group.
One goal in our original 1996 proposal was to achieve single-base resolution of DNA in the 100-
mer size range.  While this is not yet a routine achievement, we have come very close to
realizing this goal.  Figure 9 shows the MALDI spectrum from a mixture of single-stranded
synthetic DNA oligonucleotides of 99 and 101 base lengths, i.e., a 2-base difference.  The two
observed peaks are easily distinguished, although not baseline resolved.  Figure 9 suggests
that we are quite close to being able to distinguish a 1-base difference at this size.
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Figure 7.  16 (of 96 total) MALDI spectra obtained automatically following 96-well PCR
product purification. (The remaining 80 spectra are omitted due to space
considerations.)
While higher throughput has been achieved for smaller pmoA PCR products such as the 56-mer
shown in Figure 7, a good deal of patience and operator skill are still required to achieve results
such as those shown in Figure 9.  Therefore, although we have made progress in this area,
there is a need to reduce further the “art” associated with MALDI, especially for DNA that
contains 100 bases or more.  One current problem is that MALDI matrices for DNA typically
yield an uneven deposition of DNA-doped matrix crystals on the periphery of the dried sample
spot, necessitating a tedious search for “sweet spots” with the laser.  For automated, high
throughput MALDI-MS analysis of PCR products, it is important to obtain homogeneous MALDI
spots that yield good signal from any location on the spot.  We have developed a procedure
[Kim et al., 1999] using a two-layer substrate of linear polyacrylamide (LPA) or poly(ethylene
oxide) and Nafion to obtain good MALDI spectra from any part of a MALDI spot prepared with a
mixed matrix containing 3-hydroxypicolinic acid, [Wu et al., 1993] picolinic acid, and ammonium
citrate. [Tang et al., 1994]  For these experiments, MALDI spots containing a synthetic 20-mer
DNA labeled with a covalently-attached fluorescent dye (HEX) were imaged by a fluorescence
microscope equipped with a CCD camera, and subsequently subjected to MALDI-MS analysis.
While DNA/matrix crystals form only at the spot’s rim in the absence of a polymeric substrate
(Figure 10 A), the use of an LPA-Nafion substrate enhances the formation of DNA-doped matrix
crystals in the interior of the MALDI spot, as Figure 10 B clearly shows.  Not only is the spot
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more uniform, but, more importantly, good MALDI spectra were obtained from most locations on
the sample spot shown in Figure 10 B.  For a number of different MALDI sample spots, we
obtained MALDI spectra at ³14 locations for the laser within each spot.  A positive hit was
scored if the signal-to-noise ratio for the MALDI spectrum of the DNA was ³4.  For bare metal
sample plates, the hit rate was 52%, with a standard deviation of 16% determined by analyzing
6 separate sample spots.  For an LPA/Nafion substrate, the hit rate was 84±3% (12 separate
sample spots).  The hit rate, indicating within-spot ability to locate the signal, was thus
substantially higher for the LPA/Nafion substrate.  Also, the between-spot variation was reduced
for the samples prepared on the LPA/Nafion substrates.  We evaluated other potential substrate
materials, including poly(ethyleneimine), poly(decyl acrylate), poly(acrylic acid), and methyl
cellulose, none of which have yielded satisfactory results.  A manuscript describing these results
is currently in preparation.
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Figure 8.  MALDI spectra of 50-mer, 100-mer, and 200-mer PCR products.
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Figure 10.  Fluorescence micrographs of DNA in MALDI matrix spots.  A:  conventional
MALDI sample spot;  B: MALDI spot deposited on an LPA/Nafion substrate.
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Relevance, Impact and Technology Transfer
a. How does this new scientific knowledge focus on critical DOE environmental management
problems?
DNAPLs such as chloroform, carbon tetrachloride, trichlorethylene and perchloroethylene
represent a significant fraction of the pollution legacy remaining from past operations at many
DOE and industrial sites.  As these chemicals represent a significant human health risk and
have potential for migrating into drinking water supplies under the influence of geological
processes, characterization and cleanup of DNAPLs is an important part of the mission of EM,
in particular the Subsurface Contaminants Focus Area (SCFA), and its DNAPL product line.
[Phillips, 1999]
The SCFA Multi-Year Program Plan, FY 2000-2004, addresses this issue [Wright et al., 1999]:
“The capability to destroy contaminants in situ is a preferred method of remediation
because it reduces the risk both to the environment and to the public and is typically less
expensive. These techniques produce much lower levels of secondary waste, thus
reducing future waste legacies.
Access to contaminants in the diverse geologic settings across the complex is the
greatest challenge to in situ destruction.  Dense, Non-Aqueous Phase Liquid (DNAPL)
concentrations in the sediment below the water table, if not destroyed, will continue to
contaminate the aquifer for years. Promising technologies to define and treat these
areas of high concentration levels in complex hydrogeologic conditions are being
demonstrated by the SCFA.”
Because it can be applied in situ, bioremediation is thus an important weapon in the DOE
arsenal for remediation of DNAPLs.  Further information about the application of bioremediation
at DOE sites can be found in the SCFA “Rainbow Book” [U.S. DOE, 1996].
The knowledge gained as a result of this project provides proof of principle for a new method for
profiling microbial populations at DOE sites being considered for in-situ bioremediation of
organics or metals.
b. How will the new scientific knowledge that is generated by this project improve technologies
and cleanup approaches to significantly reduce future costs, schedules, and risks and meet
DOE compliance requirements?
One aspect of in-situ bioremediation where improvements are needed is characterizing and
monitoring the microbial populations that actually perform the degradation of pollutants.
[Foreman, 1999;  U.S. DOE, 1996]  In order to develop bioremediation into a reliable and cost-
effective treatment strategy for cleanup of DNAPLs, a rapid screening tool is needed for
metabolic and genetic potential of the indigenous microbial population for destroying the
particular pollutants.  A readily available, broad-brush assessment of key traits involved in
biodegradation of DNAPLs would reduce uncertainty in effectiveness and cost related to
bioremediation alternatives, and in the optimization of a cleanup system once it was
implemented.  Faster and more convenient microbial characterization techniques would enable
the selection of the bioremediation strategy most suited to a site, reducing the need for costly
pump and treat, soil excavation, or other remediation technologies that generate secondary
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waste products, expose workers to pollutants, or simply cannot be applied in unfavorable
geological circumstances.
Because of the potential cost benefits associated with in-situ bioremediation, this research could
reduce future costs by allowing broader and speedier implementation and monitoring of in-situ
bioremediation in cases where it is not presently applicable.
c. To what extent does the new scientific knowledge bridge the gap between broad fundamental
research that has wide-ranging applications and the timeliness to meet needs-driven applied
technology development?
The broad fundamental research on which this project draws lies in two areas:  1.  Molecular
biology of microbes and the sequencing of their genomes and identification of relevant genes
that degrade pollutants, and 2.  Developments in mass spectrometry that have allowed analysis
of larger biomolecules such as the PCR-amplified regions of environmentally relevant microbial
genes.  The needs-driven technology development issue addressed by this project is microbial
characterization for assessing the in situ bioremediation potential of a polluted site.  We have
narrowed the gap between broad fundamental knowledge and needs-driven technology
development by demonstrating the detection of microbial genes that degrade TCE using
molecular biology and mass spectrometry-based techniques.
d. What is the project's impact on individuals, laboratories, departments, and institutions? Will
results be used? If so, how will they be used, by whom, and when?
At ORNL, the knowledge gained as a result of this project has broadened the knowledge and
experience base of the Organic and Biological Mass Spectrometry group in the application of
mass spectrometry to DNA.  We are as a result of this project able to carry out PCR
amplification of desired products, both for specific applications and for model systems.  The
ability to desalt and purify PCR products and other small DNA molecules is also valuable in on-
going research in the group.  Because it is the genetic material common to all organisms, the
knowledge gained in this project will be helpful in collaborations with other life scientists in the
future.
Two postgraduate researchers were involved in the project at ORNL;  Dr. Yongseong Kim, now
assistant professor in the Division of Chemistry and Chemical Engineering at Kyungnam
University in Masan, South Korea, and Kristal Weaver, presently senior research assistant at
the Human Immunology and Cancer Research Program, University of Tennessee--Knoxville.
At the University of Washington, two graduate students have been partially supported in their
Ph.D. research by this project.  Dr. Andria Costello is now an assistant professor at Syracuse
University, in the Department of Civil & Environmental Engineering.  Ann Auman is currently
completing her Ph.D. studies in Prof. Lidstrom’s laboratory.
e. Are larger scale trials warranted? What difference has the project made? Now that the project
is complete, what new capacity, equipment or expertise has been developed?
Because of the encouraging preliminary results obtained in this project, we have submitted a
renewal proposal to the EMSP to continue this work.  The scope of the work in the renewal
period would involve development of a wider array of microbial gene probes tailored for mass
spectrometry detection, as well as demonstration of the technology on groundwater samples
from Lake Washington and DOE sites .
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f.  How have the scientific capabilities of collaborating scientists been improved?
The interdisciplinary nature of the work, involving molecular biology and analytical chemistry,
has broadened the knowledge base of both groups.
g.  How has this research advanced our understanding in the area?
A DNA sequence database was developed for methanotrophs in Lake Washington sediment.  It
was found that a significant segment of the natural population are sMMO-containing
Methylomonas  strains.  These strains are of interest because they have the potential to carry
out high rate degradation of trichloroethylene (TCE) and are more easily enriched than the
classical Methylosinus strains that are normally the target of methane-enhanced bioremediation
protocols.
Improved methods for mass spectrometric analysis of PCR products were developed.  This
involved optimization of a purification procedure, which was implemented in a rapid, parallel
fashion, and development of a sample substrate that shows promise for producing more
homogeneous, and therefore more easily analyzed, DNA/matrix mixtures for MALDI-MS.
h.  What additional scientific or other hurdles must be overcome before the results of this project
can be successfully applied to DOE Environmental Management problems?
The two major hurdles remaining before this project could be applied to DOE Environmental
Management problems are (1) further improvements in robustness for the mass spectrometry
detection of PCR amplification products, and (2) development of “mass spectrometry friendly”
gene probes for a broader range of microbial metabolic functions relevant to bioremediation.
These two hurdles are addressed in our renewal proposal, currently under review.
i.  Have any other government agencies or private enterprises expressed interest in the project?
Please provide contact information.
No.
Project Productivity
Initially, we proposed two fully-funded projects--one at ORNL, and the other at the University of
Washington.  Only the ORNL proposal was funded in 1996.  However, because of the
importance of the work proposed by Prof. Lidstrom’s group to the success of the project, we
supported a small subset of the proposed UW research through a subcontract.  For this reason,
the goals originally proposed were not fully achieved.  To be more specific, the original pair of
proposals outlined work to identify products of DNAPL metabolism using electrospray/ion trap
mass spectrometry;  this work was not performed due to funding at a lower level than requested
originally.  However, we did demonstrate proof of principle for the mass spectrometric detection
of gene probe assays for microbial genes relevant to bioremediation.
Personnel Supported
Oak Ridge National Laboratory:
Michelle V. Buchanan, PI Associate Division Director, Life Sciences Division (LSD)
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Gregory B. Hurst Research Staff, Chemical and Analytical Sciences Division
(CASD)
David P. Allison Research Staff, LSD
Phillip F. Britt Research Staff, CASD
Mitchel J. Doktycz Research Staff, LSD
Yongseong Kim Postdoctoral Research Program, ORISE
Kristal Weaver Postgraduate Research Program, Oak Ridge Institute for Science
and Education (ORISE)
University of Washington:
Mary E. Lidstrom Frank Jungers Professor of Chemical Engineering and Professor
of Microbiology
Andria M. Costello Ph.D. Student
Ann Auman Ph.D. Student
Publications
Articles stemming from the research which were:
a. Published in peer-reviewed journals and books.
G.B. Hurst, K. Weaver, M.J. Doktycz, M.V. Buchanan, A.M. Costello and M.E. Lidstrom.
“MALDI-TOF Analysis of Polymerase Chain Reaction Products from Methanotrophic Bacteria,”
Anal. Chem. 1998, 70, 2693-2698.  Results were summarized above in Section 5.
A.M. Costello and M.E. Lidstrom,  “Molecular characterization of functional and phylogenetic
genes from natural populations of methanotrophs in lake sediments,”  Appl. Env. Microbiol.
1999, 65, 5066-5073.  Results were summarized above in Section 5.
b.  Published in unreviewed publications (proceedings, technical reports, etc.).
G.B. Hurst, K. Weaver, M.V. Buchanan and M.J. Doktycz,  "Analysis of PCR products using
delayed-extraction MALDI-TOF,"  Proceedings of the 45th ASMS Conference on Mass
Spectrometry and Allied Topics, Palm Springs CA, June 1-5, 1997, p. 843.
G.B. Hurst, K. Weaver, M.J. Doktycz, M.V. Buchanan, A. Costello, and M.E. Lidstrom,
"Identification of Methanotrophic Bacteria Using the Polymerase Chain Reaction with MALDI-
TOF Detection,"  Proceedings of the 46th ASMS Conference on Mass Spectrometry and Allied
Topics, Orlando FL, May 31-June 4, 1998, p. 1202.
K. Weaver, M.J. Doktycz, P.F. Britt, G.B. Hurst, and M.V. Buchanan, "96-Well Microtiter-Format
Purification of DNA for MALDI-TOF Analysis," Proceedings of the 46th ASMS Conference on
Mass Spectrometry and Allied Topics, Orlando FL, May 31-June 4, 1998, p. 60.
Y. Kim, G.B. Hurst, M.J. Doktycz and M.V. Buchanan, “Improved Spot Homogeneity for DNA
MALDI Matrices,” Proceedings of the 47th ASMS Conference on Mass Spectrometry and Allied
Topics, Dallas TX, June 13-18, 1999.
c.  Accepted/submitted for publication.
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Auman, Ann J., Sergei Stolyar, and Mary E. Lidstrom, “Molecular characterization of
methanotrophic isolates from freshwater lake sediment,”  submitted to Appl. Env. Microbiol.
(2000).
Interactions
a.  Participation/presentations at meetings, workshops, conferences, seminars, etc.
G. B. Hurst, K. Weaver, and M.V. Buchanan,  "Improved Mass Spectrometric Resolution for
PCR Product Size Measurement,"  presented at The Sixth Department of Energy Contractor
and Grantee Workshop of the Human Genome Program, Santa Fe, NM, November 9-13, 1997.
M.V. Buchanan, G.B. Hurst, M.J. Doktycz, P.F. Britt, K. Weaver, M.E. Lidstrom and A.J.
Costello,  “Monitoring Genetic and Metabolic Potential for in situ Bioremediation:  Mass
Spectrometry,”  Poster presentation at the DOE Environmental Management Science Program
Workshop, Chicago, Ill., July 27-30, 1998.
G.B. Hurst, Y. Kim, K. Weaver and M.V. Buchanan, “PCR Product Size Measurement using
MALDI Mass Spectrometry,” Poster presentation at the 7th DOE Human Genome Contractor-
Grantee Workshop, Oakland, California, January 12-16, 1999.
G.B. Hurst, M.V. Buchanan, M.J. Doktycz, P.F. Britt, Y. Kim, K. Weaver, M.E. Lidstrom, A.M.
Costello, A. Auman, “Monitoring Genetic and Metabolic Potential for in situ Bioremediation:
Mass Spectrometry,”  Oral presentation at the DOE-ORO EMSP Workshop, Oak Ridge, TN,
September 22, 1999.
M.V. Buchanan, G.B. Hurst, M.J. Doktycz, P.F. Britt, K. Weaver, M.E. Lidstrom and A.J.
Costello,  “Monitoring Genetic and Metabolic Potential for in situ Bioremediation:  Mass
Spectrometry,”  Poster presentation at the DOE Environmental Management Science Program
Workshop 2000, Atlanta, Ga., April 24-28, 2000.
b.  Consultative and advisory functions to other laboratories and agencies, especially DOE and
other government laboratories.
None.
c.  Collaborations
The project itself was collaborative, but did not involve collaboration with others not directly
involved in the project.
Transitions
Due to its more fundamental nature in keeping with the EMSP philosophy, this research has not
progressed to a point of being applied by personnel involved in DOE or other remediation
activities.
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Patents
None
Future Work
The two major hurdles remaining before this project could be applied to DOE Environmental
Management problems are (1) further improvements in robustness for the mass spectrometry
detection of PCR amplification products, and (2) development of “mass spectrometry friendly”
gene probes for a broader range of microbial metabolic functions relevant to bioremediation.
These two hurdles are addressed in our renewal proposal, currently under review.
Literature Cited
J. Bai, Y. Liu, X. Liang, Y. Zhu, and D.M. Lubman, “Procedures for Detection of DNA by Matrix-
assisted Laser Desorption/Ionization Mass Spectrometry Using a Modified Nafion Film
Substrate,” Rapid Commun. Mass Spectrom. 9, 1172-1176 (1995).
E.J. Bouwer and A.J.B. Zehnder, “Bioremediation Of Organic-Compounds - Putting Microbial-
Metabolism To Work,” Tr. Biotech. 11, 360-367 (1993).
J.P. Bowman, L. Jimenez, I. Rosario, T.C. Hazen, and G.S. Sayler, “Characterization Of The
Methanotrophic Bacterial Community Present In A Trichloroethylene-Contaminated Subsurface
Groundwater Site,” Appl. Environ. Microbiol. 59, 2380-2387 (1993).
M.V. Buchanan, G.B. Hurst, M.J. Doktycz, P.F. Britt, K. Weaver, M.E. Lidstrom and A.J.
Costello,  “Monitoring Genetic and Metabolic Potential for in situ Bioremediation:  Mass
Spectrometry,”  Poster presentation at the DOE Environmental Management Science Program
Workshop, Chicago, Ill., July 27-30, 1998.  Available on the Internet at
http://www.doe.gov/em52/1998posters/id55108.pdf
A.M. Costello and M.E. Lidstrom,  “Molecular characterization of functional and phylogenetic
genes from natural populations of methanotrophs in lake sediments,”  Appl. Env. Microbiol. 65,
5066-5073 (1999).
A.M. Costello, “Molecular Ecology Studies of Methanotrophs in a Freshwater Lake Sediment.”
Ph.D. Thesis, California Institute of Technology, Pasadena, CA, 1999.  Available from UMI, 300
N. Zeeb Rd, Ann Arbor, MI, UMI # 9930380.
M.J. Doktycz, G.B. Hurst, S. Habibi-Goudarzi, S.A. McLuckey, K. Tang, C.H. Chen, M. Uziel,
K.B. Jacobsen, R.P. Woychik and M.V. Buchanan, “Analysis of Polymerase Chain Reaction-
Amplified DNA Products by Mass Spectrometry Using Matrix-Assisted Laser Desorption and
Electrospray:  Current Status,” Anal. Biochem. 230, 205-214 (1995).
J.B. Fenn, M. Mann, C.K. Wong, and C.M. Whitehouse, “Electrospray Ionization For Mass-
Spectrometry Of Large Biomolecules,” Science 246, 64-71 (1989).
S. Foreman, “Reactivity of Organics in the Hanford Subsurface,” in the “EM Needs Management
System,” Need ID RL-SS32-S, found at http://EM-Needs.em.doe.gov/Home/Entry.asp. (1999)
23
R.A. Gibbs, “DNA Amplification By The Polymerase Chain-Reaction,” Anal. Chem. 62, 1202-
1214 (1990).
T.C. Hazen, "Test plan for in situ bioremediation demonstration of the Savannah River Inte-
grated Demonstration project." Technical Report No. WSRC-RD-91-23.  Westinghouse Savan-
nah River Company, Aiken, SC, (1991).
F. Hillenkamp, M. Karas, R.C. Beavis, and B.T. Chait, “Matrix-Assisted Laser
Desorption/Ionization Mass Spectrometry of Biopolymers,” Anal. Chem. 63, 1193A (1991).
G.B. Hurst, M.J. Doktycz, A.A. Vass, and M.V. Buchanan, “Detection of Bacterial DNA
Polyerase Chain Reaction Products by Matrix-assisted Laser Desorption/Ionization Mass
Spectrometry,” Rapid Commun. Mass Spectrom . 10, 377-382 (1996).
G.B. Hurst, K. Weaver, M.J. Doktycz, M.V. Buchanan, A.M. Costello, and M.E. Lidstrom,
"MALDI-TOF Analysis of Polymerase Chain Reaction Products from Methanotrophic Bacteria,"
Anal. Chem. 70, 2693-2698 (1998a).
G.B. Hurst, K. Weaver, M.J. Doktycz, M.V. Buchanan, A.M. Costello and M.E. Lidstrom,
"Identification of Methanotrophic Bacteria using the Polymerase Chain Reaction with MALDI-
TOF Detection," Oral presentation at the 46th ASMS Conference on Mass Spectrometry and
Allied Topics, Orlando, FL, May 31-June 4, 1998b.
M.A. Innis and D.H. Gelfand, “Optimization of PCRs,” Chapter 1 in PCR Protocols:  A Guide to
Methods and Applications, M.A. Innis, D.H. Gelfand, J.J. Sninsky and T.J. White, eds.,
Academic Press, San Diego (1990).
Y. Kim, G.B. Hurst, M.J. Doktycz and M.V. Buchanan, “Improved Spot Homogeneity for DNA
MALDI Matrices,” Proceedings of the 47th ASMS Conference on Mass Spectrometry and Allied
Topics, Dallas TX, June 13-18, 1999.
Y.-H. Liu, J. Bai, X. Liang, D.M. Lubman and P.J. Venta, “Use of a Nitrocellulose Film Substrate
in Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry for DNA Mapping and
Screening,” Anal. Chem. 67, 3482-3490 (1995).
W.D. Murray and M. Richardson, “Progress Toward The Biological Treatment Of C(1) And C(2)
Halogenated Hydrocarbons,” Crit. Rev. Environ. Sci. Tech. 23, 195-217 (1993).
E. Phillips, Product Line Manager, “Dense Nonaqueous Phase Liquids Product Line Mission,”
included in the Subsurface Contaminants Focus Area home page at
http://www.envnet.org/scfa/prodlines/dnapl/dnapl-gen-info.htm#mission (1999).
K. Tang, N.I. Taranenko, S.L. Allman, C.H. Chen, L.Y. Chang and K.B. Jacobson, “Picolinic acid
as a matrix for laser mass spectrometry of nucleic acids and proteins,”  Rapid Commun. Mass
Spectrom. 8, 673-677 (1994).
United States Department of Energy, Office of Environmental Management, Office of Science
and Technology, Subsurface Contaminants Focus Area Rainbow Book, found at
http://ost.em.doe.gov/ifd/RbBooks/scfa/scfarb.htm (1996).
24
K. Weaver, M.J. Doktycz, P.F. Britt, G.B. Hurst and M.V. Buchanan, "96-Well Microtiter-Format
Purification of DNA for MALDI-TOF Analysis,"  Poster presentation at the 46th ASMS
Conference on Mass Spectrometry and Allied Topics, Orlando, FL, May 31-June 4, 1998.
J.A. Wright, T.F. Heenana, G. Chamberlain and R. Nace, “Fiscal Years 2000-2004 Subsurface
Contaminants Focus Area Multi-Year Program Plan,”  U.S. Department of Energy, Office of
Environmental Management,  available on the WWW at http://www.envnet.org/scfa/docs/mypp-
00/ (1999).
K.J. Wu, A. Steding, C.H. Becker, Rapid Commun. Mass Spectrom. 7, 142-146 (1993).
D.S. Wunschel, K.F. Fox, A. Fox, J.E. Bruce, D.C. Muddiman, and R.D. Smith, Rapid Commun.
Mass Spectrom. 10, 29 (1996).
25
Appendix
G.B. Hurst, K. Weaver, M.J. Doktycz, M.V. Buchanan, A.M. Costello and M.E. Lidstrom.
“MALDI-TOF analysis of polymerase chain reaction products from methanotrophic bacteria,”
Anal. Chem. 1998, 70, 2693-2698.
A.M. Costello and M.E. Lidstrom,  “Molecular characterization of functional and phylogenetic
genes from natural populations of methanotrophs in lake sediments,”  Appl. Env. Microbiol.
1999, 65, 5066-5073.
G.B. Hurst, K. Weaver, M.V. Buchanan and M.J. Doktycz,  "Analysis of PCR products using
delayed-extraction MALDI-TOF,"  Proceedings of the 45th ASMS Conference on Mass
Spectrometry and Allied Topics, Palm Springs CA, June 1-5, 1997, p. 843.
G.B. Hurst, K. Weaver, M.J. Doktycz, M.V. Buchanan, A. Costello, and M.E. Lidstrom,
"Identification of Methanotrophic Bacteria Using the Polymerase Chain Reaction with MALDI-
TOF Detection,"  Proceedings of the 46th ASMS Conference on Mass Spectrometry and Allied
Topics, Orlando FL, May 31-June 4, 1998, p. 1202.
K. Weaver, M.J. Doktycz, P.F. Britt, G.B. Hurst, and M.V. Buchanan, "96-Well Microtiter-Format
Purification of DNA for MALDI-TOF Analysis," Proceedings of the 46th ASMS Conference on
Mass Spectrometry and Allied Topics, Orlando FL, May 31-June 4, 1998, p. 1017.
Y. Kim, G.B. Hurst, M.J. Doktycz and M.V. Buchanan, “Improved Spot Homogeneity for DNA
MALDI Matrices,” Proceedings of the 47th ASMS Conference on Mass Spectrometry and Allied
Topics, Dallas TX, June 13-18, 1999.
